Preserving a person is the half of cryonics we can do. Reversing it is the half we cannot.
"We cannot reverse it yet" covers several distinct problems, and some are much closer to solved than others. This is the technical companion to why revival is currently not possible.
Warming is the dangerous direction
The first surprise is that cooling is the easy half. Warming is where things break.
Cooling can be done slowly and carefully. Rewarming has to be fast, because slow rewarming gives ice a second chance to form.
A vitrified sample has to pass back up through a temperature range where the glass-like structure can partially crystallize.
That process is called devitrification, and it undoes precisely what vitrification achieved.
Ice is not the only hazard on the way up. Uneven warming builds thermal stress, and the same glass-like state that resists ice can crack under it.
So a rewarming method has to beat two failure modes at once, and the fix for one tends to make the other worse.
For a single cell this is manageable. A cell rewarms in under a minute in a warm bath, and the whole volume heats at once.
Scale changes the problem completely. A large object does not warm evenly: the outside heats faster than the inside, and different tissues heat at different rates.
Wherever a region lags, it can cross back through the ice-forming range while its neighbors are already safe.
So the requirement is not speed alone. The entire volume has to warm quickly and uniformly, and uniformity is the harder half.
Two approaches are being pursued. One uses high intensity focused ultrasound, demonstrated on a nematode that was rewarmed and revived.
The other is nanowarming: seeding tissue with magnetic nanoparticles that are heated from within by an alternating magnetic field, so the heat starts everywhere at once.
Every method under study is demonstrated on something small. The step from small to human is not a matter of building a bigger machine.
The toxicity has to come back out
There is a deeper reason rewarming is hard, and it is chemical rather than thermal.
The cryoprotectants that make preservation possible are harmless at cryogenic temperatures, where all chemistry is paused.
They are toxic once things warm up. So the wash-out is a race against the same clock the warming is racing.
The agents have to be removed quickly and cleanly during rewarming, before they can harm tissue, and evenly across the whole body.
Those two demands pull against each other. Fast warming leaves less time for removal, and slower warming invites ice.
Scale works against you here as well. Washing the agents out means moving fluid through a vascular network that has spent years at cryogenic temperature.
No technique does both at human scale today. It is one of the central unsolved problems of the field, and it is also why a living person cannot be preserved.
Reducing the toxicity at the source is the other line of attack. That is a long research road rather than a solved problem: see advancing the field.
And the original problem is still waiting
Grant perfect rewarming and perfect detoxification. You would still be holding a patient with the disease or injury that caused legal death.
On top of that sits whatever ischemic and preservation damage accumulated along the way.
Reversal in the full sense means repairing all of it, so serious thinking about revival reaches for technologies that do not exist yet.
This is the lock people skip when they picture revival. Rewarming gets the attention because it is dramatic, and curing the disease is the harder half.
A patient preserved after metastatic cancer needs the cancer cured, not only the cold undone. Of the two problems, the preservation is the easier one.
The most detailed roadmap is Robert Freitas's Cryostasis Revival. It sketches two broad routes.
The conventional route scans the vitrified structure, then extracts cryoprotectant and uses molecular machines to repair tissue during rewarming.
The more radical route, molecular reconstruction, maps the brain atom by atom and rebuilds from that map.
Both are firmly future technology, and both rest on the nanotechnology bet. The broader menu is in how we might achieve revival.
What has actually been done, and at what scale
Implying that reversal is hypothetical at every scale would be dishonest. Some locks have opened, and which ones is worth stating precisely.
A rabbit kidney has been vitrified, rewarmed, transplanted and shown to function. That is a genuine whole-organ round trip, reported in 2009.
In 2023 the same round trip ran with nanowarming. Rat kidneys were vitrified, stored cryogenically for up to 100 days, rewarmed from within, and transplanted into recipients that lived on that kidney alone.
Work on brain tissue has shown functional recovery after vitrification, and the current papers are collected in relevant research papers.
Organs are the right next rung, and the reason is vasculature. Nanowarming depends on distributing particles through blood vessels, which an organ has and a block of tissue does not.
Now the honest part. A rat kidney is about the size of a grape and has one job.
A human brain is far larger, vastly more complex, and the thing being restored is not filtration but the structure of a person.
The gap spans size, complexity, and the requirement to repair the cause of death as well.
What the record shows is a direction of travel, from impossible toward hard, one scale at a time. It does not show a schedule.
TL;DR: Reversible human cryopreservation requires safe rewarming, cryoprotectant removal and repair of preservation damage and the original illness. These capabilities do not currently exist at whole-human scale.
Take the cryopreservation guide with you
Get a practical guide to the procedure, its limits and the decisions involved.
Loading the interactive tool...
Further reading